Geneos Wealth Management Inc. Aravive, Inc. Transaction History

Geneos Wealth Management Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$0.93 - $1.9 $11,913 - $24,339	-12,810 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$3.67 - $5.8 $26,424 - $41,760	7,200 Added 128.34%	12,810 $47,000
Q1 2021 Jun 17, 2021	BUY	$5.11 - $9.24 $28,667 - $51,836	5,610 New	5,610 $29,000

28.1K

Ticker ARAV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,518,300
Description
Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of pl...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.